Lincomycin Oral Capsules/Tablets 250mg, 500 mg Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules/Tablets
Available Strengths: 250mg, 500 mg
Reference Brands: Lincocin (US)
Category: Antibiotics
Lincomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide elongation. It effectively treats severe Gram-positive infections, such as skin and soft tissue infections. Benefits include rapid bacterial eradication, high efficacy against resistant strains, and oral administration for outpatient care when used appropriately.
Product Description:
Lincomycin capsules and tablets are approved in the EU and US for treating severe Gram-positive infections, including skin, soft tissue, and bone infections. In the EU, brands like Lincocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We ensure seamless market access for lincomycin formulations, adhering to European and US standards for safe, effective antibacterial therapy.
Lincomycin Oral Capsules/Tablets — third party manufacturing & bulk supply
Lincomycin Oral Capsules/Tablets 250mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Lincomycin Oral Capsules/Tablets is supplied as Oral Capsules/Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Lincomycin Oral Capsules/Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lincomycin Oral Capsules/Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
